Viking Therapeutics, Inc. Balance Sheet
VKTX / Health Care|12 years of annual SEC 10-K data (FY2014-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 12 fiscal years. All figures from audited SEC 10-K filings.
Viking Therapeutics, Inc. had $716M in total assets and $639M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $165.8M | $26.7M | $55.5M | $36.6M | $26.4M | $29.1M | $8.4M | $9.0M | $9.0M | $768.5K | $755.9K | $755.9K |
| Current Assets | $715.6M | $907.2M | $367.2M | $167.0M | $210.5M | $256.1M | $283.5M | $302.1M | $21.9M | $14.0M | $15.2M | $773.7K |
| Total Assets | $715.7M | $908.3M | $368.5M | $168.5M | $210.7M | $256.5M | $284.3M | $302.3M | $22.1M | $14.5M | $15.4M | $3.0M |
| Current Liabilities | $76.7M | $27.4M | $19.1M | $21.9M | $8.8M | $12.1M | $6.8M | $4.5M | $8.7M | $6.5M | $2.0M | $22.5M |
| Shareholders' Equity | $639.1M | $880.3M | $348.4M | $145.3M | $201.9M | $244.3M | $277.1M | $297.8M | $13.5M | $8.0M | $8.7M | -$22.1M |